crambescin b has been researched along with veratridine in 1 studies
| Studies (crambescin b) | Trials (crambescin b) | Recent Studies (post-2010) (crambescin b) | Studies (veratridine) | Trials (veratridine) | Recent Studies (post-2010) (veratridine) |
|---|---|---|---|---|---|
| 5 | 0 | 4 | 1,755 | 0 | 86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, Y; Cho, Y; Ishikawa, Y; Konoki, K; Nakane, Y; Nakazaki, A; Nishikawa, T; Tsukamoto, T; Wakamori, M; Yotsu-Yamashita, M | 1 |
1 other study(ies) available for crambescin b and veratridine
| Article | Year |
|---|---|
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
Topics: Animals; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Pyrimidines; Spiro Compounds; Veratridine; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2017 |